![]() SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. | ![]() SomaLogic SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics. | ||
Founding Date | Founding Date 1979 | Founding Date 2001 | Founding Date 2000 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations Lane Cove West, AU HQ Gif Sur Yvette, FR Hamburg, DE Shibuya, JP Clayton West, GB Indianapolis, US | Locations Boulder, US HQ |
Employees | Employees 3699% increase | Employees 466 | Employees 483 |
Valuation ($) | Valuation ($) 539.3 m | Valuation ($) 760.8 m | Valuation ($) 396.2 m |
Financial | |||
Revenue (est.) | Revenue (est.) $126.1m (FY, 2024) | Revenue (est.) $198.6m (FY, 2025) | Revenue (est.) $97.7m (FY, 2022) |
Cost of goods | Cost of goods $33m (FY, 2024) | Cost of goods $35.2m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $93.1m (FY, 2024) | Gross profit $164.7m (FY, 2025) | Gross profit N/A |
Net income | Net income ($11.5m) (FY, 2024) | Net income $20.7m (FY, 2025) | Net income ($109.2m) (FY, 2022) |

Nanosonics is a company that specializes in the field of infection prevention.
View company
SomaLogic's breakthrough SOMAscan(tm) technology unlocks protein biomarkers for life sciences research, drug discovery and development, and new diagnostics.
View company